Clinical trial
Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon…
NCT00139204 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00139204 |
|---|---|
| Title | Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients |
| Official title | An Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine (C11 MET) in Prostate Cancer, as Assessed by Positron Emission Tomography (PET) |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Beth Israel Deaconess Medical Center Massachusetts General Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Procedure |
| Interventions | C11 Methionine PET scan |
| Enrollment | 20 |
| Start date | Apr 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | Nov 2, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: